Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common stock	Additional paid-in capital	Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated deficit	Accumulated deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2021			75,752,664
Beginning balance at Dec. 31, 2021	$ 121,463	$ (44,838)	$ 8	$ 932,944	$ (53,527)	$ (811,534)	$ 8,689	$ 45
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock (in shares)			165,675
Stock-based compensation	10,983			10,983
Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)			77,496
Issuance of common stock pursuant to Employee Stock Purchase Plan	595			595
Issuance of common stock for restricted stock units vested (in shares)			518,577
Net loss	(57,785)					(57,785)
Other comprehensive income	(385)							(385)
Exercise of stock option (in shares)			39,525
Exercise of stock options (in dollars)	126			126
Ending balance (in shares) at Mar. 31, 2022			76,553,937
Ending balance at Mar. 31, 2022	30,159		$ 8	891,121		(860,630)		(340)
Beginning balance (in shares) at Dec. 31, 2021			75,752,664
Beginning balance at Dec. 31, 2021	121,463	$ (44,838)	$ 8	932,944	$ (53,527)	(811,534)	$ 8,689	45
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(114,251)
Other comprehensive income	(559)
Ending balance (in shares) at Jun. 30, 2022			76,736,224
Ending balance at Jun. 30, 2022	(16,461)		$ 8	901,141		(917,096)		(514)
Beginning balance (in shares) at Mar. 31, 2022			76,553,937
Beginning balance at Mar. 31, 2022	30,159		$ 8	891,121		(860,630)		(340)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock (in shares)			165,675
Stock-based compensation	9,999			9,999
Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)			8,607
Net loss	(56,466)					(56,466)
Other comprehensive income	(174)							(174)
Exercise of stock option (in shares)			8,005
Exercise of stock options (in dollars)	21			21
Ending balance (in shares) at Jun. 30, 2022			76,736,224
Ending balance at Jun. 30, 2022	(16,461)		$ 8	901,141		(917,096)		(514)
Beginning balance (in shares) at Dec. 31, 2022			94,423,181
Beginning balance at Dec. 31, 2022	12,077		$ 10	1,044,864		(1,032,223)		(574)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock (in shares)			55,225
Stock-based compensation	8,127			8,127
Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)			249,623
Issuance of common stock pursuant to Employee Stock Purchase Plan	367			367
Issuance of common stock for restricted stock units vested (in shares)			716,067
Net loss	(49,165)					(49,165)
Other comprehensive income	138							138
Ending balance (in shares) at Mar. 31, 2023			95,444,096
Ending balance at Mar. 31, 2023	(28,456)		$ 10	1,053,358		(1,081,388)		(436)
Beginning balance (in shares) at Dec. 31, 2022			94,423,181
Beginning balance at Dec. 31, 2022	12,077		$ 10	1,044,864		(1,032,223)		(574)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(91,661)
Other comprehensive income	$ 93
Exercise of stock option (in shares)	0
Ending balance (in shares) at Jun. 30, 2023			95,452,703
Ending balance at Jun. 30, 2023	$ (62,800)		$ 10	1,061,555		(1,123,884)		(481)
Beginning balance (in shares) at Mar. 31, 2023			95,444,096
Beginning balance at Mar. 31, 2023	(28,456)		$ 10	1,053,358		(1,081,388)		(436)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	8,197			8,197
Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)			8,607
Net loss	(42,496)					(42,496)
Other comprehensive income	(45)							(45)
Ending balance (in shares) at Jun. 30, 2023			95,452,703
Ending balance at Jun. 30, 2023	$ (62,800)		$ 10	$ 1,061,555		$ (1,123,884)		$ (481)